Malaria Home >

FDA Approves Coartem, New Malaria Treatment Drug

The U.S. Food and Drug Administration has approved Coartem tablets (artemether and lumefantrine) for the treatment of acute, uncomplicated malaria infections in adults and children weighing at least five kilograms (approximately 11 pounds). Coartem is expected to be available within 4-6 weeks from the approval date. For more details, see www.fda.gov/bbs/topics/NEWS/2009/NEW01989.html*.

* Links to non-Federal organizations found at this site are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by CDC or the Federal Government, and none should be inferred. CDC is not responsible for the content of the individual organization Web pages found at these links.